Histologically confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate)
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the breast
Histologically confirmed prostate adenocarcinoma within  days prior to randomization.
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed prostate adenocarcinoma
Histologically confirmed prostate adenocarcinoma
Histologically-confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed prostate adenocarcinoma at the time of surgery
Documented histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate, who meet the following criteria:
Histologically confirmed adenocarcinoma of the prostate
Histologically documented adenocarcinoma of the prostate
Histologically documented adenocarcinoma of the prostate
Documented histologically confirmed adenocarcinoma of the prostate
Histologically documented adenocarcinoma of the prostate
Histologically-confirmed adenocarcinoma of the prostate
Documented histologically confirmed adenocarcinoma of the prostate
Histologically confirmed prostate adenocarcinoma
Histologically confirmed primary non-metastatic adenocarcinoma of the prostate
Documented histologically confirmed adenocarcinoma of the prostate
Histologically confirmed prostate cancer
Histologically confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate)
Histologically confirmed primary non-metastatic adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate from a prostate biopsy or prostatectomy specimen (primary site), or histological confirmation of adenocarcinoma/carcinoma in a metastatic site of disease in the setting of elevated prostate specific antigen (PSA) and imaging consistent with metastatic prostate cancer, or history of prostate cancer with documented metastasis, or histologically confirmed other solid tumor malignancy, multiple myeloma, or plasmacytoma with pathological confirmation of metastasis
Patients must have a histologically confirmed diagnosis of adenocarcinoma of the prostate
Histologically-confirmed adenocarcinoma of the prostate
All patients must have histologically confirmed prostate adenocarcinoma, with biopsies obtained within twelve months of patient registration
Histologically confirmed diagnosis of prostate cancer.
Histologically confirmed prostate adenocarcinoma within  days of registration
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Diagnosis of prostate adenocarcinoma as confirmed by the investigator
Histologically confirmed prostate cancer (not exclusive of adenocarcinoma)
Histologically confirmed prostate cancer, currently with progressive disease
Males with histologically confirmed adenocarcinoma of the prostate
Documented histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically documented adenocarcinoma of the prostate
Histologically confirmed metastatic adenocarcinoma of the lung
Histologically documented adenocarcinoma of the prostate
Histologically confirmed, castrate-resistant adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the rectum
Histologically confirmed, locally confined adenocarcinoma of the prostate
Histologically documented adenocarcinoma of the prostate
Diagnosis of prostate adenocarcinoma as confirmed by the investigator
Histologically confirmed, localized adenocarcinoma of the prostate
Histologically documented adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
COHORT A: The subject must have histologically confirmed adenocarcinoma of the prostate with tissue confirmation at selected study site
Subject has histologically confirmed metastatic adenocarcinoma of the prostate.
Patients must have histologically confirmed adenocarcinoma of the prostate gland
Histologically confirmed adenocarcinoma of the prostate
Participants must have histologically confirmed prostate cancer.
Histologically confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate)
Histologically confirmed adenocarcinoma of the prostate with metastatic disease.
Histologically confirmed diagnosis of prostate cancer
Histologically confirmed adenocarcinoma of the prostate.
Documented histologically confirmed adenocarcinoma of the prostate
Documented histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Documented histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically-confirmed adenocarcinoma of the prostate
Histologically-documented localized (stage < T) prostate adenocarcinoma
History of histologically confirmed prostate cancer
Histologically confirmed adenocarcinoma of the prostate.
Histologically confirmed prostate cancer
Histologically confirmed adenocarcinoma of the prostate
Histologically confirmed adenocarcinoma of the prostate
Histologically-confirmed prostate cancer
Patients with histologically confirmed prostate cancer
Histologically confirmed primary adenocarcinoma of the prostate
Participants must have histologically confirmed prostate cancer
Histologically confirmed diagnosis of prostate cancer
Histologically confirmed adenocarcinoma of the prostate
Patients with histologically confirmed prostate cancer
